FGFR2 and Crouzon syndrome: In conclusion, this study demonstrates that the Crouzon syndrome associated C342Y mutation in Fgfr2 enhances early osteoblast differentiation but inhibits later differentiation of bone marrow stromal cells into fully functional osteoblasts when cultured in a conventional in vitro monolayer system and when allowed to differentiate in a three-dimensional matrix in vivo.